N/A N=58 BIONICS Israel Trial
Stenosis
Primary: Device Success in the Target Lesion as Determined by the Angiographic Core Laboratory — 58 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=81 Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas
Recurrent Glioblastoma
Primary: Progression-Free Survival at 6 Months (PFS-6) — 31; 15 percentage of participants
N/A N=129 A Home-based Training Program for Elderly Patients With Dementia
Dementia
Primary: Caregivers' Self-efficacy — 155; 178 units on a scale
Phase 4 N=87 REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension
Pulmonary Arterial Hypertension
Primary: Change From Baseline in Right Ventricular Stroke Volume (RVSV) to Week 26 — 15.17 milliliters (mL)
N/A N=179 Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies
Eosinophilic Esophagitis
Primary: Number of Participants With Respiratory Complications — 0; 0; 15; 0 Participants — p=<0.0001
N/A N=89 Evaluation of Investigational (Frequent Replacement) FRP Lens for Daily Wear
Ametropia
Primary: Slit Lamp Findings for Epithelial Edema — 106; 58; 0; 0 Eyes
N/A N=29 Food Additives Effects on EEG Profiles in College Students With ADHD
Attention Deficit Hyperactivity Disorder
Primary: Mean Power (EEG) During AFC and Placebo Challenge in ADHD and Control Groups — 3.19; 3.09; 3.50; 2.13 Mean Power (microvolts^2) — p=>0.05
Phase 2 N=88 Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Choroidal Neovascularization · Age-related Macular Degeneration
Primary: Change From Baseline in Best Corrected Visual Acuity (BCVA) in the Study Eye at Month 3 — .3; 6.8; 7.6 Letters
Phase 2 N=23 Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome
Constrictive Bronchiolitis · Bronchiolitis Obliterans · Graft vs Host Disease
Primary: Overall Response to Treatment Based on Positive Response to Cyclosporine Inhalation Solution (CIS) — 9; 0 Participants
N/A N=83 Study on the Level of Neuromuscular Blockade
Neuromuscular Blockade
Primary: Plasma Concentration of D-lactic Acid Before the Surgery — 1100.4; 1087.8 ng/ml
Phase 3 N=79 Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy
Malignant Head and Neck Neoplasm · Mucositis · Radiation-Induced Disorder
Primary: Change in Pain Associated With Radiation-induced Mucositis, (Pain Subscale of the Vanderbilt Head and Neck Symptom Survey (VHNSS)) — 4.26; 3.68 score on a scale — p=0.004
N/A N=104 MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR)
de Novo or Restenosis Lesions
Primary: Target Lesion Failure (TLF) — 2 Participants
N/A N=50 Whole-body Vibration With or Without Localized Radiofrequency and Body Composition in Obese Female
Obesity
Primary: Body Composition — 44.8; 43.4; 44.0 PECENTAGE OF WHOLE-BODY FAT
N/A N=96 Effectiveness of Osteopathic Manipulative Therapy in Nonsynostotic Plagiocephaly
Nonsynostotic Plagiocephaly
Primary: Number of Participants With Change From Baseline in ODDI Score (Oblique Diameter Difference Index) to Below 104% at 3 Months — 23; 3; 25; 45 Participants — p=0.01
Phase 1 N=18 Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation
Cystic Fibrosis
Primary: Intra-subject Change From Baseline of CFTR-mediated Total Chloride Transport as Measured by Nasal Potential Difference (NPD). — 1.86; -0.75; -1.11; 1.66 mV